Orchid Pharma has informed that pursuant to Regulation 30 read with Para 15 of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and in continuation to letter dated August 06, 2024 intimating the schedule of Board Meeting, an Analysts/Investors Earning Call hosted by ‘Systematix Institutional Equities’ is scheduled to be held on Tuesday, August 13, 2024 at 04:00 PM (IST) to discuss the financial performance/ financial results of the Company for the Quarter-1 of financial year 2024-25, ended on June 30, 2024. The aforesaid information will also be hosted on the Company’s website at www.orchidpharma.com.
The above information is a part of company’s filings submitted to BSE.
